Gordian Advisors LLC purchased a new position in Colgate-Palmolive (NYSE:CL – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,800 shares of the company’s stock, valued at approximately $602,000. Colgate-Palmolive makes up 0.5% of Gordian Advisors LLC’s investment portfolio, making the stock its 15th biggest holding.
A number of other large investors also recently modified their holdings of CL. Price T Rowe Associates Inc. MD lifted its position in Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares during the period. Legal & General Group Plc boosted its stake in Colgate-Palmolive by 0.8% during the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after buying an additional 61,413 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its holdings in Colgate-Palmolive by 4.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock worth $629,220,000 after acquiring an additional 278,150 shares during the period. Finally, Acadian Asset Management LLC raised its position in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock worth $551,367,000 after acquiring an additional 2,955,442 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts have issued reports on the stock. Barclays lifted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Bank of America lifted their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, Morgan Stanley increased their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded down $1.57 during trading hours on Wednesday, reaching $92.69. 1,007,347 shares of the company were exchanged, compared to its average volume of 4,340,768. Colgate-Palmolive has a 12 month low of $74.67 and a 12 month high of $109.30. The firm has a market cap of $75.73 billion, a price-to-earnings ratio of 27.01, a PEG ratio of 3.33 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a 50-day moving average of $101.80 and a 200 day moving average of $98.45.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.16%. Colgate-Palmolive’s payout ratio is presently 57.31%.
Insider Buying and Selling
In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Buy P&G Now, Before It Sets A New All-Time High
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
- Compound Interest and Why It Matters When Investing
- 3 Rising-Margin Stocks with Strong Growth Potential
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.